Psychedelics' Potential to Address Spinal Cord Injury with Joel Castellanos, MD and Jim Harris

Psychedelics' Potential to Address Spinal Cord Injury with Joel Castellanos, MD and Jim Harris

Author: Lynn Marie Morski, MD, JD January 11, 2023 Duration: 57:16

In this episode of the Psychedelic Medicine Podcast, Dr. Joel Castellanos and Jim Harris join to discuss the possibilities of addressing spinal cord injuries using psychedelic medicine. Dr. Castellanos is a board certified physical medicine and rehabilitation and pain management physician and an associate professor in the department of anesthesiology at University of California, San Diego School of Medicine. Jim Harris is a National Geographic photographer who suffered a spinal cord injury during one of his adventures who became notable in the psychedelic space with the article in Outside "Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms."

Jim starts off by sharing his own backstory of how he broke nine vertebrae in his spine during a 2014 ski expedition in Patagonia, Chile, leading to significant loss of motion and sensation. After some promising success in traditional rehabilitation and physical therapy settings, Jim details his surprising experience of healing with psilocybin. 

In this vein, Dr. Castellanos discusses the importance of neuroplasticity in healing for spinal cord injury patients. He talks about how forming new neural pathways can help a patient regain function and sensation in a part of the body that had previously been paralyzed, and leveraging this neuroplasticity using psychedelics and other tools may be a promising way to improve outcomes among these traditionally underserved patients. 

Considering the unique needs of spinal cord injury patients, Jim wonders whether lower doses of psychedelics may be more beneficial for this population, as it would allow them to maintain a greater degree of sobriety and groundedness to pursue physical therapy and rehabilitation activities while under the influence of the substance. 

Dr. Castellanos expresses excitement about the possibilities of psychedelic therapies for these patients, as not only does early anecdotal evidence such as Jim's story suggest that these substances may be effective in helping to facilitate regain of function and sensation, but also because of the mental changes brought on by a psychedelic experience. Patients may feel more optimistic and eager to apply themselves following a psychedelic experience, which will facilitate healing beyond just what occurs as a result of the effects of the substance itself. He is also encouraged by current research into different forms of neuroplasticity which have different mechanisms. Dr. Castellanos suggests employing these in combination, such as using psychedelic therapy alongside vagus nerve stimulation, may offer more effective treatment options for spinal cord injury patients. 

At the end of this conversation, Jim poses Dr. Castellanos a fascinating question: whether there may be any downsides to over-encouraging neuroplasticity. Dr. Castellanos responds that there could be certain risks of increasing pain in patients, as neuroplasticity encourages new connections to be formed in the brain, but it matters what specifically becomes more interconnected. As such, there is reason to proceed with caution even as neuroplasticity offers significant benefits. 

In closing, Jim shares some hard reduction tips for other spinal cord injury patients interested in exploring psychedelic healing. Both he and Dr. Castellanos are optimistic at the possibilities of psychedelic therapies used in conjunction with other treatments for patients like Jim. 

 

In this episode:

  • Leveraging neuroplasticity using psychedelics and other tools to help physical medicine and rehabilitation patients regain function
  • Anecdotes of other spine injury patients who've regained function or sensation following a psychedelic experience
  • The connection between spasticity and psychedelics
  • How the response to psychedelics has changed over time for Jim 
  • Connecting physical therapy and psychedelic therapy to improve efficacy of rehabilitation
  • How different mechanisms of neuroplasticity may be used in concert to promote recovery
  • Harm reduction tips

 

Quotes:

Jim: "[when I first took psilocybin] all of a sudden I had an ability to contract my hamstring and… lift my heel off the ground, like up toward my butt, and I hadn't been able to do that up until that time." [9:12]

Joel: "My primary focus is on neuroplasticity and ways that we can creatively modulate the nervous system to optimize recovery and optimize quality of life, whether that's from a pain perspective or a regaining motor strength perspective." [13:34]

Joel: "If we can demonstrate that through psychedelics we can optimize and improve and make recovery more efficient, it is something that will be a huge deal for a great number of patients, and make my job as a rehab physician easier." [14:37]

Jim: "The reason I've become interested in psychedelics as medicine has been trying to figure out… what are all the ways that I can have some sort of personal efficacy in my own recovery." [19:22]

Jim: "I do know of other anecdotes kinda similar to mine, of people—maybe especially it seems like with a first psychedelic experience—suddenly regaining sensory or motor functions." [22:41]

Jim: "It seems there's maybe some reason to suspect that some of the nerve plasticity that psychedelics can allow may reopen the critical period of this pivotal mental state where, say having a psychedelic and doing physical therapy in that state and maybe even the days afterwards, might result in a bigger functional change than just doing the therapy alone." [24:28]

Jim: "My hypothesis would be that a useful physical therapy dose [of psychedelics] might be a lot less than what Johns Hopkins and other institutions are dosing as a therapeutic dose. It seems to me that maybe a really high dose psychedelic experience is going to make it harder to stay connected to your body, connected to doing a task." [29:17]

Joel: "If I can identify three or four different ways to open up neuroplasticity that each have different mechanisms, it allows me to leverage those to give robust functional recovery and that's what I'm interested in." [33:56]

Joel: "If psychedelics can reframe someone's cognition and reframe their situation where that gives them a little bit of hope, along with having a supportive therapy team, along with it working on descending inhibition and activating muscles that were previously paralyzed, that's multiple different levels of approaching someone that just had the worst thing in their whole life happen to them… It builds resilience and then it's also working on the neuromuscular pathway to improve functional recovery." [37:30]

Joel: "I don't think just taking a psychedelic or other medication on its own is always going to be efficacious in solving that maladaptive pattern. But, when combined with specific and guided therapy, whether that's physical therapy, or psychotherapy, or cognitive therapy, I think that's where you can guide those neurons to a healthier connection through neuroplasticity." [50:17]

 

Links:

"Outside article: Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms."

Psychedelics and Health Research Initiative at University of California San Diego

Dr. Castellanos on Twitter

Jim on Instagram

Previous episode: Psychedelic Therapies for Pain with Joel Castellanos, MD

Fireside Project website

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Ayahuasca for PTSD with Dr. Simon Ruffell MBChB, MRCPsych, PhD [not-audio_url] [/not-audio_url]

Duration: 47:29
In this episode Dr. Simon Ruffell joins to discuss the research on ayahuasca for PTSD. Dr. Ruffell is a psychiatrist, researcher, and student of curanderismo (Amazonian shamanism) working at the intersection of Western p…
Psychedelics and Religion with Hunt Priest, MDiv [not-audio_url] [/not-audio_url]

Duration: 45:51
In this episode, Hunt Priest joins to discuss the intersection of psychedelic experiences and religion. Hunt is the founder of Ligare: A Christian Psychedelic Society and was a participant in the Johns Hopkins/NYU Psiloc…
Which Psychedelic for Which Condition? with Will Van Derveer, MD [not-audio_url] [/not-audio_url]

Duration: 45:08
In this episode, Will Van Derveer, MD joins to unpack what we know about which psychedelic medicines are best suited to particular mental health conditions. Dr. Van Derveer has trained several thousand mental health prof…
Psychedelics for the Menopause Transition with Alicia Bigelow, ND [not-audio_url] [/not-audio_url]

Duration: 35:26
In this episode, Alicia Bigelow, ND joins to discuss the potential of psychedelic medicine to support the menopause transition. Dr. Ali Bigelow is a naturopathic physician, ketamine provider and licensed psilocybin facil…
Psychedelics and Movement with Dmitry Repin, PhD [not-audio_url] [/not-audio_url]

Duration: 30:24
In this episode, Dmitry Repin, PhD joins to discuss the intersection of bodily movement and psychedelics. Dr. Repin is the co-founder of the Institute for Psychedelic Research at Tel Aviv University, holds a PhD in cogni…